More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes "everything should be over the counter" unless a...
HEALTH & FITNESS
Danaher is tapping the M&A well yet again. But we might have had enough
Danaher 's days in the portfolio may be numbered. We're again left disappointed after Danaher's latest acquisition plan failed to...
France probes Nestle, Danine over baby formula toxins: What to know
A crisis over contaminated baby formula has grown with product recall after recall in recent weeks. On Friday, Paris' public...
Florida law models what genetic disease testing could be
In Florida, a new genetic disease screening program allows parents of newborns to receive free whole genome sequencing at birth,...
Moderna says FDA refuses to review application for flu shot
The Food and Drug Administration has refused to start a review of Moderna's application for its experimental flu shot, the...
Medicare coverage opens 15 million-patient opportunity
Novo Nordisk CEO Mike Doustdar on Wednesday said the company is aiming to capture around 15 million new patients, at...
How largest health-care educator in US is tackling a growing jobs gap
When Steve Beard took on the role of CEO at higher education firm Adtalem Global Education in 2021, the company...
Novo Nordisk faces defining year in the obesity drug market
Mike Doustdar, CEO of Novo Nordisk, speaks in the Oval Office during an event about weight loss drugs at the...
CVS Health (CVS) earnings Q4 2025
A pedestrian walks by a CVS store in Greenbrae, California, on July 31, 2025.Justin Sullivan | Getty ImagesCVS Health on...
FDA says Novo Nordisk’s obesity pill TV ad includes misleading claims
Still life of the new Wegovy semaglutide tablets on a white background. Its a prescription medicine used with a reduced...
Novo Nordisk sues Hims & Hers over compounded obesity drugs
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4,...
Hims & Hers pulls copycat weight-loss pill after legal threats
Piotr Swat | Lightrocket | Getty ImagesHims & Hers on Saturday said that it will pull its copycat weight-loss pill...
Pfizer execs talk Metsera obesity drug
Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York...
White House launches direct to consumer drug site
U.S. President Donald Trump makes an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov....
Eli Lilly gaining in GLP-1 market over Novo Nordisk, earnings show
The Eli Lilly and Novo Nordisk logos.Mike Blake | Tom Little | ReutersIt's a tale of two drugmakers in the...
Eli Lilly (LLY) earnings Q4 2025
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025. Antranik Tavitian...
Pfizer’s monthly obesity injection drove shows promise in trial
Smith Collection | Archive Photos | Getty ImagesPfizer on Tuesday said its experimental obesity drug, which it acquired through Metsera,...
Merck (MRK) earnings Q4 2025
Merck on Tuesday reported fourth-quarter earnings and revenue that topped estimates on strong demand for its cancer immunotherapy Keytruda and...
Pfizer (PFE) earnings Q4 2025
Albert Bourla, CEO of Pfizer, speaking on Squawk on the Street at the World Economic Forum in Davos, Switzerland on...
Eli Lilly CEO David Ricks talks Medicare coverage of obesity pills
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for...
